198 related articles for article (PubMed ID: 31744781)
1. Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorder.
Nestsiarovich A; Kerner B; Mazurie AJ; Cannon DC; Hurwitz NG; Zhu Y; Nelson SJ; Oprea TI; Crisanti AS; Tohen M; Perkins DJ; Lambert CG
Psychoneuroendocrinology; 2020 Feb; 112():104511. PubMed ID: 31744781
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 71 bipolar disorder pharmacotherapies for kidney disorder risk: The potential hazards of polypharmacy.
Nestsiarovich A; Kerner B; Mazurie AJ; Cannon DC; Hurwitz NG; Zhu Y; Nelson SJ; Oprea TI; Unruh ML; Crisanti AS; Tohen M; Perkins DJ; Lambert CG
J Affect Disord; 2019 Jun; 252():201-211. PubMed ID: 30986735
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological treatment of bipolar disorder and risk of diabetes mellitus: A nationwide study of 30,451 patients.
Rohde C; Köhler-Forsberg O; Nierenberg AA; Østergaard SD
Bipolar Disord; 2023 Jun; 25(4):323-334. PubMed ID: 36751986
[TBL] [Abstract][Full Text] [Related]
4. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD.
Goldberg JF; Brooks JO; Kurita K; Hoblyn JC; Ghaemi SN; Perlis RH; Miklowitz DJ; Ketter TA; Sachs GS; Thase ME
J Clin Psychiatry; 2009 Feb; 70(2):155-62. PubMed ID: 19210946
[TBL] [Abstract][Full Text] [Related]
5. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
6. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
7. Hypothyroidism risk compared among nine common bipolar disorder therapies in a large US cohort.
Lambert CG; Mazurie AJ; Lauve NR; Hurwitz NG; Young SS; Obenchain RL; Hengartner NW; Perkins DJ; Tohen M; Kerner B
Bipolar Disord; 2016 May; 18(3):247-60. PubMed ID: 27226264
[TBL] [Abstract][Full Text] [Related]
8. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials.
Correll CU
J Am Acad Child Adolesc Psychiatry; 2007 Jun; 46(6):687-700. PubMed ID: 17513981
[TBL] [Abstract][Full Text] [Related]
9. Association of Lithium Treatment With the Risk of Osteoporosis in Patients With Bipolar Disorder.
Köhler-Forsberg O; Rohde C; Nierenberg AA; Østergaard SD
JAMA Psychiatry; 2022 May; 79(5):454-463. PubMed ID: 35353126
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive comparison of monotherapies for psychiatric hospitalization risk in bipolar disorders.
Nestsiarovich A; Mazurie AJ; Hurwitz NG; Kerner B; Nelson SJ; Crisanti AS; Tohen M; Krall RL; Perkins DJ; Lambert CG
Bipolar Disord; 2018 Dec; 20(8):761-771. PubMed ID: 29920885
[TBL] [Abstract][Full Text] [Related]
11. Psychotropic use and risk of stroke among patients with bipolar disorders: 10-year nationwide population based study.
Wu CS; Wu KY; Lo YR; Huang YW; Tsai YT; Li Y; Tsai HJ
J Affect Disord; 2018 Jan; 226():77-84. PubMed ID: 28964996
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis.
Vieta E; Valentí M
CNS Drugs; 2013 Jul; 27(7):515-29. PubMed ID: 23749421
[TBL] [Abstract][Full Text] [Related]
13. Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP.
Haeberle A; Greil W; Russmann S; Grohmann R
BMC Psychiatry; 2012 Sep; 12():153. PubMed ID: 22998655
[TBL] [Abstract][Full Text] [Related]
14. Lamotrigine combined with divalproex or lithium for bipolar disorder: a case series.
Redmond JR; Jamison KL; Bowden CL
CNS Spectr; 2006 Dec; 11(12):915-8. PubMed ID: 17146405
[TBL] [Abstract][Full Text] [Related]
15. Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.
Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
J Clin Psychiatry; 2006 Jul; 67(7):1055-61. PubMed ID: 16889448
[TBL] [Abstract][Full Text] [Related]
16. Open-label, concomitant use of lamotrigine and other medications for bipolar disorder.
Bowden CL; Edwards S; Evoniuk G
CNS Spectr; 2008 Jan; 13(1):75-83. PubMed ID: 18204417
[TBL] [Abstract][Full Text] [Related]
17. Mood stabilisers and risk of stroke in bipolar disorder.
Chen PH; Tsai SY; Pan CH; Chang CK; Su SS; Chen CC; Kuo CJ
Br J Psychiatry; 2019 Jul; 215(1):409-414. PubMed ID: 30295208
[TBL] [Abstract][Full Text] [Related]
18. Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.
Torrent C; Amann B; Sánchez-Moreno J; Colom F; Reinares M; Comes M; Rosa AR; Scott J; Vieta E
Acta Psychiatr Scand; 2008 Jul; 118(1):4-18. PubMed ID: 18498432
[TBL] [Abstract][Full Text] [Related]
19. Polypharmacy and suicide attempts in bipolar disorder.
Gazalle FK; Hallal PC; Tramontina J; Rosa AR; Andreazza AC; Zanatto V; Santin A; Kapczinski F; Ceresér KM
Braz J Psychiatry; 2007 Mar; 29(1):35-8. PubMed ID: 17435926
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
